MedKoo Cat#: 412950 | Name: Cirazoline free base

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cirazoline free base is a full agonist at the α1A adrenergic receptor, a partial agonist at both the α1B and α1D adrenergic receptors, and a nonselective antagonist to the α₂ adrenergic receptor. It is believed that this combination of properties could make cirazoline an effective vasoconstricting agent.

Chemical Structure

Cirazoline free base
Cirazoline free base
CAS#59939-16-1 (free base)

Theoretical Analysis

MedKoo Cat#: 412950

Name: Cirazoline free base

CAS#: 59939-16-1 (free base)

Chemical Formula: C13H16N2O

Exact Mass: 216.1263

Molecular Weight: 216.28

Elemental Analysis: =C, 72.19; H, 7.46; N, 12.95; O, 7.40

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Cirazoline free base; Cirazolina; Cirazolinum;
IUPAC/Chemical Name
1H-Imidazole, 2-((2-cyclopropylphenoxy)methyl)-4,5-dihydro-
InChi Key
YAORIDZYZDUZCM-UHFFFAOYSA-N
InChi Code
InChI=1S/C13H16N2O/c1-2-4-12(11(3-1)10-5-6-10)16-9-13-14-7-8-15-13/h1-4,10H,5-9H2,(H,14,15)
SMILES Code
C1(COC2=CC=CC=C2C3CC3)=NCCN1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 216.28 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Angel I, Le Rouzic M, Pimoule C, Graham D, Arbilla S. [3H]cirazoline as a tool for the characterization of imidazoline sites. Ann N Y Acad Sci. 1995 Jul 12;763:112-24. doi: 10.1111/j.1749-6632.1995.tb32396.x. PMID: 7677320. 2: Ruffolo RR Jr, Waddell JE. Receptor interactions of imidazolines. IX. Cirazoline is an alpha-1 adrenergic agonist and an alpha-2 adrenergic antagonist. J Pharmacol Exp Ther. 1982 Jul;222(1):29-36. PMID: 6123592. 3: McMahon LR, Morien A, Davies BT, Wellman PJ. Conditioned taste aversion in rats induced by the alpha 1-adrenoceptor agonist cirazoline. Pharmacol Biochem Behav. 1994 Jul;48(3):601-4. doi: 10.1016/0091-3057(94)90320-4. PMID: 7938112. 4: Docherty JR, McGrath JC. The actions of cirazoline on the rat vas deferens. Br J Pharmacol. 1984 May;82(1):9-14. doi: 10.1111/j.1476-5381.1984.tb16436.x. PMID: 6145469; PMCID: PMC1987249. 5: Wellman PJ, Davies BT. Reversal of cirazoline- and phenylpropanolamine- induced anorexia by the alpha 1-receptor antagonist prazosin. Pharmacol Biochem Behav. 1992 May;42(1):97-100. doi: 10.1016/0091-3057(92)90452-l. PMID: 1356275. 6: Tabrizchi R, Lupichuk SM. The effects of losartan and captopril on vasopressor actions of cirazoline in the absence and presence of SZL-49 and nifedipine. J Cardiovasc Pharmacol. 1995 Jul;26(1):137-44. doi: 10.1097/00005344-199507000-00022. PMID: 7564355. 7: Wellman PJ, Davies BT. Effects of the alpha 1-adrenergic agonist cirazoline on locomotion and brown adipose tissue thermogenesis in the rat. Life Sci. 1992;50(23):1745-53. doi: 10.1016/0024-3205(92)90057-v. PMID: 1350850. 8: Smith EF 3rd, Slivjak MJ, Gagnon R. Single and repeated doses of the vasodilator/beta-adrenergic antagonist, carvedilol, block cirazoline- and isoproterenol-mediated hemodynamic responses in the conscious rat. Cardiovasc Drugs Ther. 1992 Oct;6(5):499-504. doi: 10.1007/BF00055608. PMID: 1360255. 9: Le Rouzic M, Angel I, Schoemaker H, Allen J, Arbilla S, Langer SZ. Binding of [3H]cirazoline to an imidazoline site in rat brain and kidney membranes. Eur J Pharmacol. 1995 May 24;278(3):261-4. doi: 10.1016/0014-2999(95)00177-m. PMID: 7589165. 10: Cavero I, Lefèvre-Borg F, Roach AG, Gomeni R, Scatton B. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats. J Pharmacol Exp Ther. 1982 Oct;223(1):241-50. PMID: 6126583.